semaglutide v tirzepatide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management Tirzepatide vs Semaglutide | Best

While some people respond to taking a very small dose called super responders others cannot tolerate moving up to the next higher standard dose and need something in between. This helps explain why one recent study among patients with diabetes found that microdosing helped them stick with their GLP-1s, reducing side effects without compromising efficacy

Outside of obesity management, sample focus areas for the metabolic disease leaders include using GLP-1s to address obesity-related or -exacerbated risks like kidney damage and osteoarthritis

For patients with type 2 diabetes, glycemic control is a critical eligibility factor

Many patients find that GI side effects improve after completing the dose escalation period, though some may experience persistent symptoms